PC

Polymerase Capital

North America, Washington, United States, Seattle

Description

Polymerase Capital is a venture capital firm focused on life science companies.

Investor Profile

Polymerase Capital has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Polymerase Capital frequently co-invest with?

DeepWork Capital
North America, Florida, United States, Orlando
Co-Investments: 1
UO
North America, Florida, United States, Gainesville
Co-Investments: 1
Pacira Pharmaceuticals
North America, California, United States, San Diego
Co-Investments: 1

What are some of recent deals done by Polymerase Capital?

Genascence

Palo Alto, California, United States

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases

Biotechnology
Series AJan 7, 2022
Amount Raised: $10,500,000